VWF and arrhythmogenic right ventricular cardiomyopathy: We observed increased activation of the coagulation system in the myocardium of patients with ARVC; in Des-/- mice, we observed increased levels of thrombin, fibrinogen, and von Willebrand factor, as well as deposits of activated C3, in areas of cardiac tissue injury.